| Literature DB >> 31597647 |
Katharina Dohms1, Marc Hein1, Rolf Rossaint1, Mark Coburn1, Christian Stoppe2, Constanze Barbara Ehret1, Tanja Berger3, Gereon Schälte4.
Abstract
OBJECTIVES: Whether spinal anaesthesia (SA) reduces intraoperative and postoperative complications compared with general anaesthesia (GA) was investigated.Entities:
Keywords: apnoea; general anaesthesia; herniorrhaphy; neonates; spinal anaesthesia
Year: 2019 PMID: 31597647 PMCID: PMC6797401 DOI: 10.1136/bmjopen-2018-028728
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow diagram of the meta-analysis based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement.
Baseline data of the included studies
| Name, publication year | Type | Study design | n | Sex, male, n (%) | Gesta-tional age, mean (weeks) | Postconceptual age, mean (weeks)±SD | Presenting weight, mean (g)±SD | Type of anaesthetic | Pre-existing lung conditions,* n (%) | Required oxygen before surgery, n (%) | Supplemental medication |
| Welborn | SA | RCT | 11 | NA | 31.3±2.6 | 43.3±3.9 | NA | Tetracaine, epinephrine | 3 (28) | NA | NOA |
| GA | 16 | NA | 31.8±3.9 | 40.5±3.4 | NA | Halothane, N2O/O2 | 6 (38) | NA | NOA | ||
| Krane | SA | RCT | 9 | 7 (78) | 29.9±3.6 | 42.3±4.1 | 3300±700 | Tetracaine | 7 (78) | NA | N2O IO; NOA |
| GA | 9 | 7 (78) | 29.9±3.9 | 40.9±2.1 | 3270±2100 | Halothane, N2O | 6 (67) | NA | NOA | ||
| Somri | SA | RCT | 20 | NA | 33.1±4.0 | 43.7 | 3700±1100 | Bupivacaine | 8 (40) | 6 (30) | PCM (20) |
| GA | 20 | NA | 32.7±3.2 | 44.15 | 3340±1376 | FI: thiopental; FM: halothane; N2O/O2 | 6 (20) | NA | PCM (40) | ||
| Kim | SA | RCS | 15 | NA | 27.5±1.9 | 41.1±2.8 | 2937±755 | Bupivacaine | 15 (100) | 15 (100) | Ketamine IO (73.3); oxygen IO (60) |
| GA | 14 | NA | 27.8±1.7 | 40.2±2.6 | 2806±541 | FI: thiopental; FM: enflurane and N2O/O2 | 14 (100) | 11 (79) | Ketamine IO; | ||
| Lambertz | SA | RCS | 69 | 60 (87) | NA | NA | 4047±1002 | Bupivacaine | 11 (16)† | NA | NA |
| GA | 31 | 26 (84) | NA | NA | 5327±1376 | FI: Propofol, piritramide; FM: propofol | 3 (10)† | NA | Remifentanyl IO | ||
| Davidson | SA | RCT | 102 | 84 (82) | 32.5±3.2 | 43.0±3.8 | 3633±919 | (Levi-)Bupivacaine | 55 (54) | 46 (45) | NOA PRO (5); vasoactives IO (1.9); NOA PO (46); OA PO (0) |
| GA | 196 | 169 (86) | 32.6±2.3 | 43.9±4.3 | 3891±1062 | Sevoflurane | 104 (53) | 79 (40) | NOA PRO (8); vasoactives IO (6); NOA PO (32); OA PO (1); epinephrine PO (0.5) |
*Patients with apnoea, IRDS, ever required mechanical ventilation or medication for apnoea before surgery.
†Pre-existing diseases.
FI, for introduction; FM, for maintenance; GA, general anaesthesia; IO, intraoperatively; NA, not answered; N2O, nitrous oxide; NOA, non-opioid analgesics; OA, opioid analgesics; PCM, paracetamol; PO, postoperatively; PRO, preoperatively; RCS, retrospective cohort study; RCT, randomised controlled trial; SA, spinal anaesthesia.
Figure 2Postoperative apnoea: (A) any episode of apnoea, (B) prolonged apnoea, (C) postoperative oxygen supplementation, and (D) postoperative mechanical ventilation.
Figure 3Postoperative bradycardia.